Navigation Links
Darryl Neil Penenberg, PhD. is recognized by Continental Who's Who as a Pinnacle Professional in the Pharmaceutical Industry
Date:6/20/2013

NEW YORK, June 20, 2013 /PRNewswire/ -- /Continental Who's Who/ -- Darryl Neil Penenberg, PhD. is recognized by Continental Who's Who as a Pinnacle Professional in the Pharmaceutical Industry as a result of his role as President of DNP Consultants, a company specializing in design and analysis of clinical trials data used for the development of new drugs and vaccines, clinical program development, protocol design, statistical trouble-shooting, and report/dossier preparation/review for regulatory submission. 

Dr. Penenberg is a Biostatistician and Global Regulatory Affairs Professional with more than 26 years of experience in clinical trial analyses and regulatory submission auditing in the Pharmaceuticals industry. After establishing DNP Consultants in 2012, he focused his practice on clinical trials for pain, epilepsy, post-operative gastro intestinal surgery, advanced medical illness, HIV and AIDS, oncology, cardiovascular disease, as well as psychiatric and orthopedic clinical trials. As President of DNP, Dr. Penenberg oversees all daily operations of the consultancy, including managing the activities of the firm's Biostatistician, finance management, marketing, and meeting with clients.

Throughout his illustrious career, Dr. Penenberg has worked on phase one through four clinical trials leading to Regulatory approvals. He has expertise in experimental design, power calculations, survival analyses, categorical data analyses, de-identification of data sources, big data sampling problems and Quality of Life analyses. In addition, he has worked on the preparation of clinical study reports for Regulatory submissions, meeting abstract and journal publications as well as performing exploratory analyses for promotional response marketing modeling used for materials for sales representatives.

His mathematical interests are Algebraic Number Theory, Algebraic Geometry and Elliptic Curves and Modular Forms.

As a result of his professionalism and dedication to the Pharmaceutical Industry, Dr. Penenberg maintains affiliations with several prestigious organizations. He is an honored Fellow of the Royal Statistical Society and an Associate Member of Sigma Xi. Additionally, he is a member of the New York Biotechnology Association, New York Academy of Sciences; Stevens Alumni Association; The Society for Mathematical Biology; Biometrics Society; Institute of Mathematical Statistics; American Statistical Association; Bernoulli Society; International Statistical Institute; American Mathematical Society; Mathematical Association of America; as well as The Society of Rheology through the American Institute of Physics.

Dr. Penenberg earned his Ph.D. in Mathematics from the Stevens Institute of Technology and also holds a Master's Degree in Mathematics from the City University of New York-Hunter College. In addition, DNP Consultants holds a certification from the New York County Clerk to operate his business.

Dr. Penenberg has published in several journals including the Journal of Clinical Psychopharmacology.

For more information, please email dpenenberg@gmail.com.

About Us

Continental Who's Who has become one of the most respected and trusted publishers around the globe.  We spotlight thousands of professional individuals and organizations each year who "stand-out" in their specific field.  Included are executives and officials in business, science, education, philanthropy, religion, government, the fourth estate, finance, law, engineering, authors, the musically talented elite as well as numerous additional industries.

Our mission at Continental Who's Who is to provide an exclusive internationally recognized world-class forum where members can create social, professional and business relationships.  We provide resources, information and represent an atmosphere and opportunity to network, consult, showcase, educate, and empower, allowing for establishing new business relations to increase future success.  We are committed to delivering the highest quality service to all our established members.

Please visit us at www.continentalwhoswho.com.

Contact:  Robert Basilin, 516-825-5634, pr@continentalwhoswho.com


'/>"/>
SOURCE The Continental Who's Who
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Five physicians recognized for outstanding leadership in hand hygiene.
2. Health Decisions Recognized by CIO Magazine as a CIO 100 Award Honoree
3. Dr. Kelly A. Tomo, Pharm.D. is recognized by Continental Whos Who as a Pinnacle Professional
4. Frost & Sullivan Recognized Top Industry Innovators
5. Inovio Pharmaceuticals Recognized With "Best Therapeutic Vaccine" and "Best Early Stage Biotech" Awards at World Vaccine Congress 2013
6. Sysmex America Employee Outreach Recognized for Fifth Consecutive Year
7. Cognizant Recognized as a Leader in Life Science Drug Safety Services in IDC MarketScape
8. Lilly Recognized for Fifth Straight Year on NAFEs Top 50 Companies for Executive Women
9. Ferring Pharmaceuticals Inc. Recognized for Best-in-Class Work-Life Portfolio
10. Aribex Recognized For Growth and Quality
11. Cognizant Recognized as a Leader in Pharmaceutical Social Media Analytics in IDC MarketScape
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... 2017   Pulmatrix, Inc . (NASDAQ: PULM), a clinical ... pulmonary diseases, today announced that it has added two experts ... asthma to its Scientific Advisory Board . ... B. Moss , MD, former chief of the Pediatric Pulmonary ... Center at Stanford University, and David ...
(Date:3/27/2017)... March 27, 2017  iCAD (Nasdaq: ICAD), an ... and radiation therapy for the early identification and ... Detection received Premarket Approval (PMA) from the U.S. ... is a first-of-its-kind, concurrent-read computer aided detection solution ... latest innovation available on the PowerLook® Breast Health ...
(Date:3/27/2017)... -- PhaseRx, Inc. (NASDAQ: PZRX), a biopharmaceutical company developing ... children, today reported financial results for the fourth ... and provided an update on its corporate activities. ... during the fourth quarter of 2016 through the ... study, and with our lead development candidate, PRX-OTC, ...
Breaking Medicine Technology:
(Date:3/27/2017)... ... March 27, 2017 , ... ... clear braces. People who want straight teeth without the extensive time commitment and ... Clearwater, FL, without acquiring a referral. A custom-designed series of virtually invisible aligners ...
(Date:3/27/2017)... ... March 27, 2017 , ... This is the ... popHealth Community in 2014. It is the culmination of collaborative efforts by ... Project Group. OSEHRA Organizational Member Zato Health co-funded the ONC certification and provided ...
(Date:3/27/2017)... ... March 27, 2017 , ... M&S Technologies, the first ... for the Smart System® 20/20. CE Certification builds upon M&S's long-standing commitment to ... such as ANSI, ISO and proven test methods used in the field of ...
(Date:3/27/2017)... (PRWEB) , ... March 27, 2017 , ... ... business simulation -centric training, today announced the launch of a new research study, ... having the skills needed to execute that strategy, and the actual success of ...
(Date:3/27/2017)... ... March 27, 2017 , ... According to the American Cancer Society ... is more than 95%. Once the cancer spreads to other organs, bones, or lymph ... out how to avoid this latter group, tune in to Lifestyle Magazine ...
Breaking Medicine News(10 mins):